Within 3 years after the launch of the European Lead Factory, the first patent protecting the outcomes of a drug target programme has been filed. The patent addresses multidrug resistance in bacterial infections. This important milestone reflects the EU Lead Factory’s ability to deliver on its promise, and highlights the potential of this shared-innovation approach to drug discovery.
